AGY DCF Valuation - Allergy Therapeutics PLC

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 8 GBX -4.76%

Market Cap: £506.6m

	Allergy Therapeutics PLC LSE:AGY	UK
A	Akzo Nobel NV SWB:AKU1	NL
	Hera SpA OTC:HRASF	IT
	Charles Schwab Corp NYSE:SCHW	US
	Bradespar SA BOVESPA:BRAP4	BR
R	Renta 4 Banco SA MAD:R4	ES
	Vale SA NYSE:VALE	BR
Z	Zip Co Ltd ASX:ZIP	AU
I	Intellego Technologies AB STO:INT	SE
	AT&T Inc NYSE:T	US
	Brigade Enterprises Ltd NSE:BRIGADE	IN

AGY's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.